Journals / Cukurova Medical Journal / 2021 / Cilt: 46 - Sayı: 4

Relationship between platelet/lymphocyte ratio and no-reflow formation in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

Primer perkütan koroner girişim uygulanan ST-segment yükseklikli miyokard infarktüslü hastalarda platelet/lenfosit oranı ile no-reflow oluşumu arasındaki ilişki

Pages
1441–1448
Publication Date
2021-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PLR can be used as a predictor for no-reflow in such patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study aims to evaluate the relationship between the platelet/lymphocyte ratio (PLR) measured at admission and the occurrence of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
📊
Key Findings & Data:Materials and Methods: This study included 126 patients with acute STEMI treated with primary PCI.
💡
Conclusion & Impact:PLR can be used as a predictor for no-reflow in such patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:lenfosit · miyokard infarktüsü · no-reflow

Abstract

Purpose: This study aims to evaluate the relationship between the platelet/lymphocyte ratio (PLR) measured at admission and the occurrence of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Materials and Methods: This study included 126 patients with acute STEMI treated with primary PCI. Hemoglobin, thrombocyte, and lymphocyte levels of the patients were retrieved from the files at the time of admission. Postprocedural thrombolysis in myocardial infarction (TIMI) flow grade, postprocedural myocardial blush grade (MBG), and TIMI thrombus scale were evaluated from the coronary angiography records. Results: Patients were divided into two groups according to TIMI flow grade after PCI as normal coronary flow (n = 66) and no-reflow groups (n = 60). The no-reflow group had lower LVEF and higher PLR compared to the normal coronary flow group PLR was significantly higher in patients with lower TIMI flow grade and MBG. Conclusion: PLR measured at admission was found to be higher in STEMI patients who developed no-reflow after primary PCI compared to the normal coronary flow group. PLR can be used as a predictor for no-reflow in such patients.

Özet

Amaç: Bu çalışmanın amacı, primer perkütan koroner girişim (PKG) ile tedavi edilen akut ST-segment yükselmeli miyokard infarktüsü (STYMİ) hastalarında başvuru sırasında ölçülen platelet/lenfosit oranının (PLO) ile no-reflow fenomeni oluşumu arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Bu çalışmada, primer PKG ile tedavi edilen akut STYMİ'li 126 hasta kapsanmıştırr. Hastaların hastaneye başvuru anındaki hemoglobin, trombosit ve lenfosit düzeyleri dosya verilerinden elde edildi. Hastaların işlem sonrasındaki miyokard infarktüsünde tromboliz (TIMI) akım derecesi, miyokardın boyanma derecesi (MBG) ve TIMI trombüs ölçeği koroner anjiyografi kayıtlarından değerlendirildi. Bulgular: Hastalar PKG sonrası TIMI akım derecesine göre normal koroner akım (s=66) grubu ve azalmış koroner akım (no-reflow) grubu (s=60) olmak üzere iki gruba ayrıldı. No-reflow grupta normal koroner akım grubu ile kıyaslandığında daha düşük SVEF ve daha yüksek PLO vardı. TIMI akım derecesi ve MBG' si daha düşük olan hastalarda, PLO anlamlı olarak daha yüksekti. Sonuç: Primer PKG sonrasında no-reflow gelişen STYMİ hastalarında başvuru sırasında ölçülen PLO daha yüksek saptanmıştır. PLO, bu tür hastalarda no-reflow için bir öngörürücü olarak kullanılabilir.

🔖

Cite This Article

ÖZMEN, Ç., AKRAY, A., İLTAŞ, A., YILDIZ, P. Ö., YILDIZ, İ., AKTAŞ, H. (2021). Relationship between platelet/lymphocyte ratio and no-reflow formation in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Cukurova Medical Journal, Cilt: 46 - Sayı: 4, 1441–1448. https://ajindex.com/articles/401577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ibanez B, James S, Agewall S, Antune s MJ, Bucciar elli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST- segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with Stsegment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-77
  2. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al. 2015 ACC/AHA/SCAI Focused update on primary percutaneous coronary intervention for patients with st-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135-47
  3. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78-140
  4. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995;130:239-43
  5. Cenko E, Ricci B, Kedev S, Kalpak O, Câlmâc L, Vasiljevic Z et al. The no-reflow phenomenon in the young and in the elderly. Int J Cardiol. 2016;222:1122- 8
  6. Somuncu MU, Akgun T, Cakır MO, Akgul F, Serbest NG, Karakurt H et al. The elevated soluble ST2 predicts no-reflow phenomenon in st-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Atheroscler Thromb. 2019;26:970-8
  7. Niccoli G, D'amario D, Spaziani C, Cosentino N, Marino M, Rigattieri S, et al. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol. J Cardiovasc Med (Hagerstown). 2009;10:585-92
  8. Davies MJ, Thomas AC. Plaque fissuring–the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angin